Product
EN001
Aliases
EN001 (allogeneic umbilical cord-derived mesenchymal stem cells)
2 clinical trials
3 indications
Indication
Duchenne muscular dystrophyIndication
Charcot-Marie-Tooth DiseaseIndication
Type IAClinical trial
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1AStatus: Completed, Estimated PCD: 2022-12-20
Clinical trial
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)Status: Completed, Estimated PCD: 2022-12-28